175 related articles for article (PubMed ID: 32228842)
21. Mosaic Neurocutaneous Disorders and Their Causes.
Ruggieri M; Praticò AD
Semin Pediatr Neurol; 2015 Dec; 22(4):207-33. PubMed ID: 26706010
[TBL] [Abstract][Full Text] [Related]
22. Papular nevus spilus syndrome: old and new aspects of a mosaic RASopathy.
Torchia D; Happle R
Eur J Dermatol; 2019 Feb; 29(1):2-5. PubMed ID: 30827948
[TBL] [Abstract][Full Text] [Related]
23. Mosaic KRAS mutation in a patient with encephalocraniocutaneous lipomatosis and renovascular hypertension.
McDonell LM; Leung GK; Daoud H; Ip J; Chim S; Luk HM; Lan L; ; Boycott KM; Chung BH
Am J Med Genet A; 2018 Nov; 176(11):2523-2527. PubMed ID: 30289595
[No Abstract] [Full Text] [Related]
24. Silver-Russell and Beckwith-Wiedemann syndromes: opposite (epi)mutations in 11p15 result in opposite clinical pictures.
Eggermann T
Horm Res; 2009 Apr; 71 Suppl 2():30-5. PubMed ID: 19407494
[TBL] [Abstract][Full Text] [Related]
25. Overgrowth syndromes: a classification.
Neri G; Moscarda M
Endocr Dev; 2009; 14():53-60. PubMed ID: 19293574
[TBL] [Abstract][Full Text] [Related]
26. Mosaic Activating Mutations in FGFR1 Cause Encephalocraniocutaneous Lipomatosis.
Bennett JT; Tan TY; Alcantara D; Tétrault M; Timms AE; Jensen D; Collins S; Nowaczyk MJM; Lindhurst MJ; Christensen KM; Braddock SR; Brandling-Bennett H; Hennekam RCM; Chung B; Lehman A; Su J; Ng S; Amor DJ; ; ; Majewski J; Biesecker LG; Boycott KM; Dobyns WB; O'Driscoll M; Moog U; McDonell LM
Am J Hum Genet; 2016 Mar; 98(3):579-587. PubMed ID: 26942290
[TBL] [Abstract][Full Text] [Related]
27. [PIK3CA-related overgrowth syndrome (PROS)].
Venot Q; Canaud G
Nephrol Ther; 2017 Apr; 13 Suppl 1():S155-S156. PubMed ID: 28577738
[TBL] [Abstract][Full Text] [Related]
28. Overgrowth Syndromes Caused by Somatic Variants in the Phosphatidylinositol 3-Kinase/AKT/Mammalian Target of Rapamycin Pathway.
Akgumus G; Chang F; Li MM
J Mol Diagn; 2017 Jul; 19(4):487-497. PubMed ID: 28502730
[TBL] [Abstract][Full Text] [Related]
29. PIK3CA activating mutations in facial infiltrating lipomatosis.
Maclellan RA; Luks VL; Vivero MP; Mulliken JB; Zurakowski D; Padwa BL; Warman ML; Greene AK; Kurek KC
Plast Reconstr Surg; 2014 Jan; 133(1):12e-19e. PubMed ID: 24374682
[TBL] [Abstract][Full Text] [Related]
30. Overgrowth syndromes and new therapies.
Eng W; Hammill AM; Adams DM
Semin Pediatr Surg; 2020 Oct; 29(5):150974. PubMed ID: 33069285
[TBL] [Abstract][Full Text] [Related]
31. Genetic Evaluation of Common Neurocutaneous Syndromes.
Gürsoy S; Erçal D
Pediatr Neurol; 2018 Dec; 89():3-10. PubMed ID: 30424961
[TBL] [Abstract][Full Text] [Related]
32. Neurocutaneous vascular syndromes.
Puttgen KB; Lin DD
Childs Nerv Syst; 2010 Oct; 26(10):1407-15. PubMed ID: 20582592
[TBL] [Abstract][Full Text] [Related]
33. Oculoectodermal Syndrome - Encephalocraniocutaneous Lipomatosis Associated with NRAS Mutation.
Richters RJH; Seyger MMB; Meeuwis KAP; Rinne T; Eijkelenboom A; Willemsen MA
Acta Derm Venereol; 2020 Apr; 100(8):adv00103. PubMed ID: 31633190
[No Abstract] [Full Text] [Related]
34. Clinical and Genetic Aspects of the Segmental Overgrowth Spectrum Due to Somatic Mutations in PIK3CA.
Kang HC; Baek ST; Song S; Gleeson JG
J Pediatr; 2015 Nov; 167(5):957-62. PubMed ID: 26340871
[No Abstract] [Full Text] [Related]
35. Overgrowth syndromes with vascular malformations.
Hagen SL; Hook KP
Semin Cutan Med Surg; 2016 Sep; 35(3):161-9. PubMed ID: 27607325
[TBL] [Abstract][Full Text] [Related]
36. [Encephalocraniocutaneous lipomatosis and didymosis aplasticopsilolipara].
Martí N; Alonso V; Jordá E
Actas Dermosifiliogr; 2012 May; 103(4):341-2. PubMed ID: 22192510
[No Abstract] [Full Text] [Related]
37. Encephalocraniocutaneous lipomatosis: congenital alopecia treatment in a rare neurocutaneous syndrome.
Borgognoni L; Brandani P; Reali F; Gerlini G; Sestini S; Maio V; Reali UM
J Plast Surg Hand Surg; 2014 Dec; 48(6):449-51. PubMed ID: 24070220
[TBL] [Abstract][Full Text] [Related]
38. Sturge-Weber syndrome: from the past to the present.
Sudarsanam A; Ardern-Holmes SL
Eur J Paediatr Neurol; 2014 May; 18(3):257-66. PubMed ID: 24275166
[TBL] [Abstract][Full Text] [Related]
39. CLOVES syndrome: review of a PIK3CA-related overgrowth spectrum (PROS).
Martinez-Lopez A; Blasco-Morente G; Perez-Lopez I; Herrera-Garcia JD; Luque-Valenzuela M; Sanchez-Cano D; Lopez-Gutierrez JC; Ruiz-Villaverde R; Tercedor-Sanchez J
Clin Genet; 2017 Jan; 91(1):14-21. PubMed ID: 27426476
[TBL] [Abstract][Full Text] [Related]
40. Utility of clinical high-depth next generation sequencing for somatic variant detection in the PIK3CA-related overgrowth spectrum.
Hucthagowder V; Shenoy A; Corliss M; Vigh-Conrad KA; Storer C; Grange DK; Cottrell CE
Clin Genet; 2017 Jan; 91(1):79-85. PubMed ID: 27307077
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]